Identifying the risk factors for pancreatic fistula after laparoscopic pancreaticoduodenectomy in patients with pancreatic cancer

Table 2 Comparison of preoperative laboratory indicators between the two groups [mean ± SD, M (P25, P75), n (%)]

Laboratory index	PF group (n = 15)	Non-PF group (n = 186)	t/χ2/z value	P value
Hemoglobin (g/L)	129.93 ± 19.42	127.24 ± 16.18	0.610	0.542
PLT (× 109/L)	229.00 (197.00, 293.00)	233.00 (194.75, 289.00)	-0.113	0.910
NEUT (× 109/L)	4.70 (2.40, 5.60)	4.10 (2.90, 5.30)	-0.552	0.581
Monocyte count (× 109/L)	0.50 (0.40, 0.70)	0.50 (0.40, 0.53)	-2.020	0.043
Lymphocyte count (× 109/L)	1.60 (1.10, 1.70)	1.50 (1.20, 1.90)	-0.125	0.901
ALB (g/L)	41.57 ± 3.95	43.29 ± 4.08	-1.579	0.116
TBIL (μmol/L)	14.10 (7.90, 87.20)	27.50 (11.20, 103.15)	-1.199	0.231
Carbohydrate antigen (CA199)			2.197	0.138
≥ 35 U/mL	14 (93.33)	143 (76.88)
< 35 U/mL	1 (6.67)	43 (23.12)
Carbohydrate antigen (CA125, U/mL)	17.30 (11.50, 24.40)	15.80 (10.80, 24.20)	-0.198	0.843
AFP (ng/mL)	3.38 (2.23, 3.79)	2.87 (2.16, 3.83)	-0.443	0.658
CEA (ng/mL)	2.28 (2.01, 3.83)	3.26 (2.03, 5.32)	-1.317	0.188

PLT: Platelet count; NEUT: Neutrophil count; ALB: Albumin; TBIL: Total bilirubin; AFP: Alpha-fetoprotein; CEA: Carcinoembryonic antigen; PF: Pancreatic fistula.